T1D-CATCH Program for Type 1 Diabetes in Young Adults (T1DTechCHW Trial)

"The present study needs individuals aged 18 to 30 in order to participate. For patients younger than 18, there are 233 trials that may be applicable, while those over 65 can look into the 999 studies available."

"This medical experiment is seeking 130 participants that are in the 18-30 age range. Their primary requirements include being able to understand English or Spanish, possessing a Type 1 diabetes diagnosis for at least 6 months, and having self-identified as either non-Hispanic Black or Hispanic. Additionally, candidates must not be using any diabetes technology currently (this includes never offered, discontinued, or previously refused)."

"Aiming to measure the effect of T1DTechCHW over a nine-month period, this trial will track its efficacy through participant self-reporting. Secondary metrics such as hemoglobin A1c levels and quality of life (assessed using Diabetes Distress surveys) will also be measured. Additionally, autonomy/competence ratings and social support scores gathered from Healthcare Self-Determination survey data will be analyzed for comparison."

"Affirmatively, the information housed on clinicaltrials.gov demonstrates that this trial is presently look for participants. The research was initially posted on November 7th 2022 and recently modified on November 29th 2022. There are 130 openings at a single site."

"Affirmative. Data hosted on clinicaltrials.gov reveals that this experiment, which was first posted to the platform on November 7th 2022, is still recruiting participants. The trial requires 130 patients from a single site for completion."